IP Group has returned for a series B round raised by Ieso Digital Health, having initially acquired stakes in the business through its purchase of Touchstone.

Sunshine Insurance took part in the eye-focused gene therapy developer's series C round, which pushed its overall funding past $140m.

Coinbase Ventures contributed to a $55m round for music-focused NFT platform developer Royal while neural search technology developer Jina AI raised $30m in an SAP-backed round.

Sino Biopharmaceutical co-led the oncology treatment developer's latest round, in which it raised over $91m in funding.

The neurodegenerative disease therapy developer has set a $100m placeholder target for an offering following $140m in funding from investors including Amgen and Pivotal BioVentures.

Bringing together researchers from Italy and the US, Chroma Medicine has emerged out of stealth with series A financing led by Cormorant Asset Management.

Vifor Pharma is snapping up Lundbeck and Baxter-backed vascular drug developer Sanifit for at least $231m while solar project developer SUN Energy closed $25m in funding at a $200m valuation.

Nationwide Ventures participated in a round for the Medicare brokerage made up of $35m in equity financing and a $100m credit facility.

Sino Biopharmaceutical co-led the oncology treatment developer's latest round, in which it raised over $91m in funding.

Autonomous driving technology developer MaxiEye bagged nearly $50m in a Desay-led round while software testing technology producer Mabl raised $40m from investors including GV and Presidio Ventures.